Rheonix Executive to Address Effects of Automated Molecular Diagnostic Solutions on Laboratory Workflow

ITHACA, N.Y. — Genetic testing laboratories currently face constraints such as complex sample preparation, complicated workflow and long waits for test results. Molecular diagnostics executive Richard Montagna, Ph.D., vice president for scientific affairs for Rheonix Inc., an Ithaca-based developer of an automated molecular testing platform, will present ways to overcome some of these challenges and provide cost-effective molecular diagnostics for personalized medicine at an international conference later this month.

“We are proud of our ability to dramatically simplify what would have otherwise been very complex preparative and analytical steps by achieving fully automated processing, analysis and readout,” Montagna said.

Montagna is a featured presenter at the upcoming Sample Prep East conference in Cambridge, Mass. Sample Prep East is the 8th meeting in the Knowledge Foundation’s Sample Prep Conference Series. This conference is an internationally recognized meeting for experts in sample preparation technologies for detection, identification, diagnostics and analysis of biomedical, biological and chemical agents, substances and threats.

His talk, “Automated Sample Prep for Personalized Medicine,” will describe the company’s unique sample-to-actionable-results platform that allows a raw specimen to be analyzed in a completely unattended manner. In addition to personalized medicine applications, the system’s wide spectrum of uses will also be highlighted by description of its use for the detection of sexually transmitted infections as well as applications in the food and beverage industry.

“The Rheonix platform manages to combine the power of molecular biology, microfluidics and robotics while at the same time keeping a focus on achieving actionable results in a cost-effective manner,” said Tony Eisenhut, president of Rheonix.

Montagna has more than 35 years of leadership experience and has managed the commercialization of more than 40 biotechnology products. He has published over 40 scientific papers, holds a number of patents in the biosensor area and is an adjunct professor in the department of biological and environmental engineering at Cornell University.

The Sample Prep East conference is December 9-10 at the Hyatt Regency Cambridge. Montagna is scheduled to present at 2 p.m. on December 9.